HRH4 and Alzheimer disease: This knowledge, along with the observation that H1R or H4R blockade by itself may limit histamine-induced barrier disruption, has led to renewed interest in the role of histamine in allergic inflammation, and may lead to using blockades targeting H1R and H4R as “novel” prevention and/or treatment options for AD patients.